Notice of Closed Meeting, 1583 [2023-00241]

Download as PDF Federal Register / Vol. 88, No. 7 / Wednesday, January 11, 2023 / Notices The meeting will be held on February 15, 2023, from 11:00 a.m. to 4:30 p.m., EST. DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Instructions to access the live meeting broadcast will be posted here: https://www.cdc.gov/nchs/about/ bsc/bsc_meetings.htm. Centers for Disease Control and Prevention Centers for Disease Control and Prevention Notice of Closed Meeting [Docket No. CDC–2023–0001] Rebecca Hines, M.H.S., Designated Federal Officer, Board of Scientific Counselors, National Center for Health Statistics, Centers for Disease Control and Prevention, 3311 Toledo Road, Mailstop P–08, Hyattsville, Maryland 20782; Telephone (301) 458–4715; Email: RSHines@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: The Board of Scientific Counselors, National Center for Health Statistics (BSC, NCHS) is charged with providing advice and making recommendations to the Secretary, Department of Health and Human Services; the Director, Centers for Disease Control and Prevention (CDC); and the Director, National Center for Health Statistics, regarding the scientific and technical program goals and objectives, strategies, and priorities of NCHS. Matters to be Considered: The meeting agenda will include a Center update from the NCHS Director; an update on CDC’s Data Modernization Initiative; program updates from NCHS Division Directors; and time for Board discussion regarding current issues and topics. The Board will reserve time for public comment at the end of the day. Meeting times and agenda topics are subject to change as priorities dictate. Meeting Information: Please visit the BSC, NCHS website for details: https:// www.cdc.gov/nchs/about/bsc/bsc_ meetings.htm. Further information and the meeting agenda will be available on the BSC website, including any agenda updates and the instructions for accessing the live meeting broadcast. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)— RFA–CE23–003: Grants to Support New Investigators in Conducting Research Related to Preventing Interpersonal Violence Impacting Children and Youth. Date: February 28–March 1, 2023. Time: 8:30 a.m.–5:30 p.m., EST. Place: Videoconference. Agenda: To review and evaluate grant applications. For Further Information Contact: Carlisha Gentles, PharmD, BCPS, CDCES, Scientific Review Officer, National Center for Injury Prevention and Control, CDC, 4770 Buford Highway NE, Mailstop F–63, Atlanta, Georgia 30341, Telephone: (770) 488–1504, Email: CGentles@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Advisory Committee to the Director, Centers for Disease Control and Prevention Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2023–00407 Filed 1–10–23; 8:45 am] [FR Doc. 2023–00241 Filed 1–10–23; 8:45 am] BILLING CODE 4163–19–P BILLING CODE 4163–18–P DATES: ADDRESSES: FOR FURTHER INFORMATION CONTACT: lotter on DSK11XQN23PROD with NOTICES1 1583 VerDate Sep<11>2014 17:17 Jan 10, 2023 Jkt 259001 PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting and request for comment. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Advisory Committee to the Director, Centers for Disease Control and Prevention (ACD, CDC). This meeting is open to the public. The meeting will be webcast live via the World Wide Web. DATES: The meeting will be held on February 7, 2023, from 10 a.m. to 3:30 p.m., EST (times subject to change). The public may submit written comments on or before January 27, 2023. ADDRESSES: Information for accessing the webcast will be available at https:// www.cdc.gov/about/advisorycommittee-director/. Written comments: You may submit comments, identified by Docket No. CDC–2023–0001, by any of the following methods. Do not submit comments for the docket by email. CDC does not accept comments for the docket by email. • Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. • Mail: Kerry Caudwell, DPA, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS H21–10, Atlanta, Georgia 30329–4027. Attn: Docket number CDC–2023–0001. Instructions: All submissions received must include the Agency name and Docket Number. All relevant comments received in conformance with the https://www.regulations.gov suitability policy will be posted without change to https://www.regulations.gov, including any personal information provided. For access to the docket to read background documents or comments received, go to https://www.regulations.gov. Written public comments submitted up to 72 hours prior to the ACD meeting will be provided to ACD members before the meeting. Written comments received in advance of the meeting will be included in the official record of the meeting. FOR FURTHER INFORMATION CONTACT: Kerry Caudwell, DPA, Office of the SUMMARY: E:\FR\FM\11JAN1.SGM 11JAN1

Agencies

[Federal Register Volume 88, Number 7 (Wednesday, January 11, 2023)]
[Notices]
[Page 1583]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-00241]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of the Director, Strategic 
Business Initiatives Unit, Office of the Chief Operating Officer, CDC, 
pursuant to Public Law 92-463. The grant applications and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.
    Name of Committee: Disease, Disability, and Injury Prevention and 
Control Special Emphasis Panel (SEP)--RFA-CE23-003: Grants to Support 
New Investigators in Conducting Research Related to Preventing 
Interpersonal Violence Impacting Children and Youth.
    Date: February 28-March 1, 2023.
    Time: 8:30 a.m.-5:30 p.m., EST.
    Place: Videoconference.
    Agenda: To review and evaluate grant applications.
    For Further Information Contact: Carlisha Gentles, PharmD, BCPS, 
CDCES, Scientific Review Officer, National Center for Injury Prevention 
and Control, CDC, 4770 Buford Highway NE, Mailstop F-63, Atlanta, 
Georgia 30341, Telephone: (770) 488-1504, Email: [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-00241 Filed 1-10-23; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.